Perspective Therapeutics Inc (AMEX: CATX) kicked off on Friday, up 6.58% from the previous trading day, before settling in for the closing price of $3.19. Over the past 52 weeks, CATX has traded in a range of $1.60-$13.56.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -9.86%. While this was happening, its average annual earnings per share was recorded 3.61%. With a float of $60.73 million, this company’s outstanding shares have now reached $74.26 million.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 18.23%, while institutional ownership is 66.79%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.21 earnings per share (EPS), lower than consensus estimate (set at -0.2) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.87% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 15.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 203.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.34 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Compared to the last year’s volume of 0.92 million, its volume of 0.59 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 38.03%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 51.18%, which indicates a significant decrease from 52.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.62, while its 200-day Moving Average is $3.11. Nevertheless, the first resistance level for the watch stands at $3.48 in the near term. At $3.57, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.73. If the price goes on to break the first support level at $3.23, it is likely to go to the next support level at $3.07. Now, if the price goes above the second support level, the third support stands at $2.98.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 252.49 million has total of 74,263K Shares Outstanding. Its annual sales at the moment are 1,450 K in contrast with the sum of -79,280 K annual income. Company’s last quarter sales were recorded 290 K and last quarter income was -21,490 K.
